The Infona portal uses cookies, i.e. strings of text saved by a browser on the user's device. The portal can access those files and use them to remember the user's data, such as their chosen settings (screen view, interface language, etc.), or their login data. By using the Infona portal the user accepts automatic saving and using this information for portal operation purposes. More information on the subject can be found in the Privacy Policy and Terms of Service. By closing this window the user confirms that they have read the information on cookie usage, and they accept the privacy policy and the way cookies are used by the portal. You can change the cookie settings in your browser.
Recently, blockchain has been increasingly applied to low‐carbon supply chains, enabling consumers to track production process of low‐carbon products, thereby improving brand awareness and expanding the market. However, do the operation and construction costs of blockchain come at the expense of squeezing resources originally allocated for research and development (R&D) of carbon emission reduction...
Background
Pure red cell aplasia (PRCA) following allogeneic hematopoietic stem cell transplantation (allo‐HSCT) with ABO major incompatibility is characterized by transfusion dependent anemia. No standard treatment existed for PRCA following allo‐HSCT yet.
Study Design and Methods
We conducted a retrospective study, and reported our experience with the use of avatrombopag and lower dose rituximab...